Share on StockTwits

Baxano Surgical (NASDAQ:BAXS) CEO Kenneth Michael Reali acquired 10,000 shares of the stock in a transaction dated Friday, August 15th. The stock was purchased at an average cost of $0.38 per share, for a total transaction of $3,800.00. Following the purchase, the chief executive officer now directly owns 141,128 shares in the company, valued at approximately $53,629. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of Baxano Surgical (NASDAQ:BAXS) opened at 0.3903 on Wednesday. Baxano Surgical has a one year low of $0.36 and a one year high of $1.99. The stock’s 50-day moving average is $0.49 and its 200-day moving average is $0.85. The company’s market cap is $18.9 million.

Baxano Surgical (NASDAQ:BAXS) last released its earnings data on Tuesday, August 5th. The company reported ($0.18) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.14) by $0.04. Analysts expect that Baxano Surgical will post $-0.58 EPS for the current fiscal year.

Baxano Surgical Inc, formerly TranS1 Inc, is a medical device company focused on designing, developing and marketing products that implement its approach to treat degenerative conditions of the spine affecting the lower lumbar region.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.